A federal judge in Pennsylvania sent a joint products liability and medical malpractice suit back to Philadelphia Common Pleas Court last week, declining to apply divided circuit opinions on fraudulent-misjoinder arguments brought by the manufacturers of a tuberculosis-infected bone repair product.